Purple Biotech Ltd. (PPBT) stock
PPBTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.63+0.07 (+4.49%)
Close on Nov 13, 2026Market cap $1.52MP/E 0.0Yield –
Purple Biotech total assets
Total assets on the balance sheet at the end of each period.
Purple Biotech's total assets was $17.57M at Dec 31, 2025. For fiscal 2025 it was $17.57M, down 52.6% from the year before. The highest annual figure on record is $83.80M in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.57M | -52.6% |
| FY2024 | Dec 31, 2024 | $37.04M | -16.4% |
| FY2023 | Dec 31, 2023 | $44.30M | -18.9% |
| FY2022 | Dec 31, 2022 | $54.62M | -22.2% |
| FY2021 | Dec 31, 2021 | $70.20M | -16.2% |
| FY2020 | Dec 31, 2020 | $83.80M | +469.4% |
| FY2019 | Dec 31, 2019 | $14.72M | -0.0% |
| FY2018 | Dec 31, 2018 | $14.72M | +3.8% |
| FY2017 | Dec 31, 2017 | $14.18M | -4.9% |
| FY2016 | Dec 31, 2016 | $14.91M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $17.57M | -75.0% |
| Q4 FY2024 | Dec 31, 2024 | $37.04M | -55.8% |
| Q4 FY2023 | Dec 31, 2023 | $44.30M | +201.0% |
| Q4 FY2022 | Dec 31, 2022 | $54.62M | +217.7% |
| Q4 FY2021 | Dec 31, 2021 | $70.20M | +376.8% |
| Q4 FY2020 | Dec 31, 2020 | $83.80M | +356.0% |
| Q4 FY2019 | Dec 31, 2019 | $14.72M | +3.8% |
| Q2 FY2019 | Jun 30, 2019 | $17.19M | +15.3% |
| Q4 FY2018 | Dec 31, 2018 | $14.72M | – |
| Q2 FY2018 | Jun 30, 2018 | $18.38M | – |
| Q4 FY2017 | Dec 31, 2017 | $14.18M | – |
| Q4 FY2016 | Dec 31, 2016 | $14.91M | – |
See a number that looks wrong?